BlackRock Fund Advisors - IMMUNE PHARMACEUTICALS INC ownership

IMMUNE PHARMACEUTICALS INC's ticker is IMNP and the CUSIP is 45254C101. A total of 16 filers reported holding IMMUNE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of IMMUNE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$2,0000.0%8,931
+31.9%
0.00%
Q3 2016$2,0000.0%6,771
+12.4%
0.00%
Q2 2016$2,000
-93.1%
6,024
-91.2%
0.00%
Q1 2016$29,000
-46.3%
68,127
-6.9%
0.00%
Q4 2015$54,00073,1890.00%
Other shareholders
IMMUNE PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Geduld E E 35,000$63,0000.04%
Ifrah Financial Services, Inc. 21,956$39,0000.02%
Bank Pictet & Cie (Europe) AG 12,900$23,0000.01%
Pine River Capital Management L.P. 250,000$260,0000.00%
Virtu KCG Holdings LLC 55,599$100,0000.00%
A.R.T. Advisors, LLC 10,408$18,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 1,000$2,0000.00%
CITIGROUP INC 255$00.00%
GOLDMAN SACHS GROUP INC 33,616$60,0000.00%
MORGAN STANLEY 40$00.00%
View complete list of IMMUNE PHARMACEUTICALS INC shareholders